Study will evaluate new therapy option for patients suffering from valvular heart disease MINNEAPOLIS – Medtronic, Inc. today announced the start of the Engager™ European Pivotal Trial to pursue CE ...
A significant advancement in cardiac care, Transcatheter Aortic Valve Implantation (TAVI) is increasingly being adopted as a ...
Apollo Hospitals, Chennai has successfully treated a high-risk 67-year-old patient with complex heart disease using a rare Basilica-assisted Transcatheter Aortic Valve Implantation (TAVI) procedure, ...
Transcatheter aortic valve implantation has evolved as a viable therapeutic option for high-risk, elderly patients with symptomatic aortic stenosis in select cardiac centers with experience of the ...
Valve disposition or displacement frequently occurs during transfemoral TAVR (TF-TAVR) for AR with a self-expanding valve, because of weak anchoring force. To overcome this problem, the authors of ...
Background Transcatheter aortic valve replacement (TAVR) has increasingly emerged as one of the primary treatments for ...
WILMINGTON, Del., USA, and MUNICH, JenaValve Technology, Inc., a medical device company specializing in developing transcatheter aortic valve implantation (TAVI) systems, announced today a significant ...
Coronary artery disease frequently accompanies severe aortic stenosis and is identified in up to half of patients referred for transcatheter aortic valve implantation (TAVI).1 Yet the optimal ...
BRISBANE, Australia & MINNEAPOLIS--(BUSINESS WIRE)--Anteris Technologies Ltd, (Anteris or the Company) (ASX: AVR), a structural heart company developing DurAVR™ THV, a new class of biomimetic heart ...
The POPular TAVI trial has challenged current guideline recommendations on antiplatelet treatment after transcatheter aortic valve implantation (TAVI) in patients not taking oral anticoagulation. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results